Limited coverage drugs – risedronate

Last updated on September 26, 2024

Generic name / strength / form

risedronate 30mg tablets

Special Authority criteria Approval period

Diagnosis of Paget's disease

Indefinite

Practitioner exemptions

  • No practitioner exemptions

Special notes

  • None

Special Authority requests